Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety, Tolerability and Exploratory Efficacy of EC5026 in Parkinson's Disease (STEP Study)

NCT07142044 is registered in ClinicalTrials.gov with EicOsis Human Health Inc. as lead sponsor.

NCT NCT07142044
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07142044 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety, Tolerability and Exploratory Efficacy of EC5026 in Parkinson's Disease (STEP Study)
Lead sponsor
EicOsis Human Health Inc.
Phase
Phase 1/2
Overall status
Recruiting
Start date
November 1, 2025
Completion date
June 30, 2027
Enrollment
18 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

parkinson's disease (pd)